TECHNOLOGY FOCUS - BIOLOGY - Preparation: No preparation method is given. Preferred Components: The microbial organism comprises two, three, or four exogenous nucleic acids each encoding an enzyme of the MI-FAE cycle, the MD-FAE cycle, or the termination pathway. The exogenous nucleic acid is a heterologous nucleic acid. The non-naturally occurring microbial organism is in a substantially anaerobic culture medium. The enzyme of the MI-FAE cycle, MD-FAE cycle or termination pathway is expressed in a sufficient amount to produce a fatty alcohol compound of formulae (R1-CH(OH)-CH2-CH2-OH) (III), (R1-C(=O)-CH2-CH2-OH), (R1-CH=CH-CH2-OH) and (R1-CH2-CH2-CH2-OH) (VI). The microbial organism further comprises an acetyl-CoA pathway and at least one exogenous nucleic acid encoding an acetyl-CoA pathway enzyme expressed in a sufficient amount to produce acetyl-CoA, where the acetyl-CoA pathway comprises a pathway comprising (B1) 2A and 2B, (B2) 2A, 2C, and 2D, (B3) 2H, (B4) 2G and 2D, (B5) 2E, 2F and 2B, (B6) 2E and 2I, (B7) 2J, 2F and 2B, (B8) 2J and 21, (B9) 3A, 3B, and 3C, (B10) 3A, 3B, 3J, 3K, and 3D, (B11) 3A, 3B, 3G, and 3D, (B12) 3A, 3F, and 3D, (B13) 3N, 3H, 3B and 3C, (B14) 3N, 3H, 3B, 3J, 3K, and 3D, (B15) 3N, 3H, 3B, 3G, and 3D, (B16) 3N, 3H, 3F, and 3D, (B17) 3L, 3M, 3B and 3C, (B18) 3L, 3M, 3B, 3J, 3K, and 3D, (B19) 3L, 3M, 3B, 3G, and 3D, (B20) 3L, 3M, 3F, and 3D, (B21) 4A, 4B, 4D, 4H, 41, and 4J, (B22) 4A, 4B, 4E, 4F, 4H, 41, and 4J, (B23) 4A, 4B, 4E, 4K, 4L, 4H, 41, and 4J, (B24) 4A, 4C, 4D, 4H, and 4J, (B25) 4A, 4C, 4E, 4F, 4H, and 4J, (B26) 4A, 4C, 4E, 4K, 4L, 4H, and 4J, (B27) 5A, 5B, 5D, and 5G, (B28) 5A, 5B, 5E, 5F, and 5G, (B29) 5A, 5B, 5E, 5K, 5L, and 5G, (B30) 5A, 5C, and 5D, (B31) 5A, 5C, 5E, and 5F, and (B32) 5A, 5C, 5E, 5K, and 5L. 2A is a pyruvate oxidase (acetate-forming). 2B is an acetyl-CoA synthetase, an acetyl-CoA ligase or an acetyl-CoA transferase. 2C is an acetate kinase. 2D is a phosphotransacetylase. 2E is a pyruvate decarboxylase. 2F is an acetaldehyde dehydrogenase. 2G is a pyruvate oxidase (acetyl-phosphate forming). 2H is a pyruvate dehydrogenase, a pyruvate:ferredoxin oxidoreductase, a pyruvate:NAD(P)H oxidoreductase or a pyruvate formate lyase. 2I is an acetaldehyde dehydrogenase (acylating). 2J is a threonine aldolase. 3A is a phosphoenolpyruvate (PEP) carboxylase or a phosphoenolpyruvate (PEP) carboxykinase. 3B is an oxaloacetate decarboxylase. 3C is a malonate semialdehyde dehydrogenase (acetylating). 3D is an acetyl-CoA carboxylase or a malonyl-CoA decarboxylase. 3F is an oxaloacetate dehydrogenase or an oxaloacetate oxidoreductase. 3G is a malonate semialdehyde dehydrogenase (acylating). 3H is a pyruvate carboxylase. 3J is a malonate semialdehyde dehydrogenase. 3K is a malonyl-CoA synthetase or a malonyl-CoA transferase. 3L is a malic enzyme. 3M is a malate dehydrogenase or a malate oxidoreductase. 3N is a pyruvate kinase or a PEP phosphatase. 4A is a citrate synthase. 4B is a citrate transporter. 4C is a citrate/malate transporter. 4D is an ATP citrate lyase. 4E is a citrate lyase. 4F is an acetyl-CoA synthetase or an acetyl-CoA transferase. 4H is a cytosolic malate dehydrogenase. 41 is a malate transporter. 4J is a mitochondrial malate dehydrogenase. 4K is an acetate kinase. 4L is a phosphotransacetylase. 5A is a citrate synthase. 5B is a citrate transporter. 5C is a citrate/oxaloacetate transporter. 5D is an ATP citrate lyase. 5E is a citrate lyase. 5F is an acetyl-CoA synthetase or an acetyl-CoA transferase. 5G is an oxaloacetate transporter. 5K is an acetate kinase. 5L is a phosphotransacetylase. The microbial organism comprises two, three, four, five, six, seven or eight exogenous nucleic acids each encoding an acetyl-CoA pathway enzyme. The non-naturally occurring microbial organism further comprises one or more gene disruptions, where the gene disruptions occur in endogenous genes encoding proteins or enzymes involved in native production of ethanol, glycerol, acetate, formate, lactate, carbon dioxide, fatty acids, or malonyl-CoA by the microbial organism, or transfer of pathway intermediates to cellular compartments other than the cytosol, or native degradation of a MI-FAE cycle intermediate, MD-FAE cycle intermediate or a termination pathway intermediate by the microbial organism, and the gene disruptions confer increased production of (I) in the microbial organism. The protein or enzyme is a fatty acid synthase, an acetyl-CoA carboxylase, a biotin:apoenzyme ligase, an acyl carrier protein, a thioesterase, an acyltransferase, an ACP malonyltransferase, a fatty acid elongase, an acyl-CoA synthetase, an acyl-CoA transferase, an acyl-CoA hydrolase, a pyruvate decarboxylase, a lactate dehydrogenase, an alcohol dehydrogenase, an acid-forming aldehyde dehydrogenases, an acetate kinase, a phosphotransacetylase, a pyruvate oxidase, a glycerol-3 -phosphate dehydrogenase, a glycerol-3 -phosphate phosphatase, a mitochondrial pyruvate carrier, a peroxisomal fatty acid transporter, a peroxisomal acyl-CoA transporter, a peroxisomal carnitine/acylcarnitine transferase, an acyl-CoA oxidase, or an acyl-CoA binding protein. One or more enzymes of the MI-FAE cycle, MD-FAE cycle or the termination pathway preferentially react with an NADH cofactor or have reduced preference for reacting with an NAD(P)H cofactor, where the enzymes of the MI-FAE cycle or MD-FAE cycle are a 3- ketoacyl-CoA reductase or an enoyl-CoA reductase, and the enzymes of the termination pathway are an acyl-CoA reductase (aldehyde forming), an alcohol dehydrogenase, an acyl-CoA reductase (alcohol forming), an aldehyde decarbonylase, an acyl-ACP reductase, an aldehyde dehydrogenase (acid forming) or a carboxylic acid reductase. The non-naturally occurring microbial organism further comprises one or more gene disruptions, where the gene disruptions occur in genes encoding proteins or enzymes that result in an increased ratio of NAD(P)H to NAD(P) present in the cytosol of the microbial organism following the disruptions. The gene encoding a protein or enzyme that results in an increased ratio of NAD(P)H to NAD(P) present in the cytosol of the microbial organism following the disruptions is an NADH dehydrogenase, a cytochrome oxidase, a glycerol-3-phosphate dehydrogenase, glycerol-3-phosphate phosphatase, an alcohol dehydrogenase, a pyruvate decarboxylase, an aldehyde dehydrogenase (acid forming), a lactate dehydrogenase, a glycerol-3 -phosphate dehydrogenase, a glycerol-3-phosphate:quinone oxidoreductase, a malic enzyme or a malate dehydrogenase. The gene disruptions comprise a deletion of the genes. The microbial organism is Crabtree positive and is in culture medium comprising excess glucose, to increase the ratio of NAD(P)H to NAD(P) present in the cytosol of the microbial organism. The non-naturally occurring microbial organism further comprises at least one exogenous nucleic acid encoding an extracellular transporter or an extracellular transport system for (I). One or more endogenous enzymes involved in: native production of ethanol, glycerol, acetate, formate, lactate, carbon dioxide, fatty acids, or malonyl-CoA by the microbial organism; transfer of pathway intermediates to cellular compartments other than the cytosol; or native degradation of a MI-FAE cycle intermediate, MD-FAE cycle intermediate or a termination pathway intermediate by the microbial organism, has attenuated enzyme activity or expression levels. The enzyme is a fatty acid synthase, an acetyl-CoA carboxylase, a biotin:apoenzyme ligase, a thioesterase, an acyl carrier protein, a thioesterase, an acyltransferase, an ACP malonyltransferase, a fatty acid elongase, an acyl-CoA synthetase, an acyl-CoA transferase, an acyl-CoA hydrolase, a pyruvate decarboxylase, a lactate dehydrogenase, a short-chain alcohol dehydrogenase, an acid-forming aldehyde dehydrogenase, an acetate kinase, a phosphotransacetylase, a pyruvate oxidase, a glycerol-3-phosphate dehydrogenase, a glycerol-3-phosphate phosphatase, a mitochondrial pyruvate carrier, a peroxisomal fatty acid transporter, a peroxisomal acyl-CoA transporter, a peroxisomal carnitine/acylcarnitine transferase, an acyl-CoA oxidase, or an acyl-CoA binding protein. One or more endogenous enzymes involved in the oxidation of NAD(P)H or NADH, has attenuated enzyme activity or expression levels. The endogenous enzymes are an NADH dehydrogenase, a cytochrome oxidase, a glycerol-3-phosphate dehydrogenase, glycerol-3-phosphate phosphatase, an alcohol dehydrogenase, a pyruvate decarboxylase, an aldehyde dehydrogenase (acid forming), a lactate dehydrogenase, a glycerol-3-phosphate dehydrogenase, a glycerol-3-phosphate:quinone oxidoreductase, a malic enzyme or a malate dehydrogenase. The culture medium is separated from a non-naturally occurring microbial organism having a malonyl-CoA independent fatty acyl-CoA elongation (MI-FAE) cycle and/or a malonyl-CoA dependent fatty acyl-CoA elongation (MD-FAE) cycle in combination with a termination pathway. The compound other than (I) is a trace amount of a cellular portion of a non-naturally occurring microbial organism having a malonyl-CoA independent fatty acyl-CoA elongation (MI-FAE) cycle and/or a malonyl-CoA dependent fatty acyl-CoA elongation (MD-FAE) cycle in combination with a termination pathway.R1 = 1-17C linear alkyl.    TECHNOLOGY FOCUS - ORGANIC CHEMISTRY - Preferred Method: The method further comprises separating (I) from other components in the culture. The separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, electrodialysis, distillation, crystallization, centrifugation, extractive filtration, ion exchange chromatography, absorption chromatography, or ultrafiltration. Preferred Components: (I) has a fraction modern (Fm) value of at least 80%, preferably at least 98%. The biobased product comprises at least 5%, preferably at least 50%, of (I). The biobased product comprises a portion of (I) as a repeating unit. EXAMPLE - No suitable example given.